BIOMAT Database Logo BIOMAT Database Logo

Discovery of pyrimidine nucleoside dual prodrugs and pyrazine nucleosides as novel anti-HCV agents. 2019

Shuang Guo, and Mingshuo Xu, and Qi Guo, and Fuqiang Zhu, and Xiangrui Jiang, and Yuanchao Xie, and Jingshan Shen
CAS Key Laboratory for Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai 201203, China; University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China.

To explore the application potential of dual prodrug strategies in the development of anti-HCV agents, a variety of sofosbuvir derivatives with modifications at the C4 or N3 position of the uracil moiety were designed and synthesized. Some compounds exhibited potent anti-HCV activities, such as 4e and 8a-8c with similar EC50 values (0.20-0.22 μM) comparative to that of sofosbuvir (EC50 = 0.18 μM) in a genotype 1b based replicon Huh-7 cell line. Moreover, 8b displayed a good human plasma stability profile, and was easily metabolized in human liver microsomes expectantly. On the other hand, aiming to discover novel anti-HCV nucleosides, pyrazin-2(1H)-one nucleosides and their phosphoramidate prodrugs were investigated. Several active compounds were discovered, such as 25e (EC50 = 7.3 μM) and S-29b (EC50 = 19.5 μM). This kind of nucleosides were interesting and would open a new avenue for the development of antiviral agents.

UI MeSH Term Description Entries
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D011719 Pyrazines A heterocyclic aromatic organic compound with the chemical formula C4H4N2. Pyrazine
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069474 Sofosbuvir A uridine monophosphate analog inhibitor of HEPATITIS C VIRUS (HCV) polymerase NS5B that is used as an ANTIVIRAL AGENT in the treatment of CHRONIC HEPATITIS C. 2-((5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy)phenoxyphosphorylamino)propionic acid isopropyl ester,GS-7977,PSI 7977,PSI-7977,PSI7977,Sovaldi,7977, PSI,GS 7977,GS7977
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Shuang Guo, and Mingshuo Xu, and Qi Guo, and Fuqiang Zhu, and Xiangrui Jiang, and Yuanchao Xie, and Jingshan Shen
Advances in nucleoside monophosphate prodrugs as anti-HCV agents.
January 2010, Antiviral therapy,
Shuang Guo, and Mingshuo Xu, and Qi Guo, and Fuqiang Zhu, and Xiangrui Jiang, and Yuanchao Xie, and Jingshan Shen
Discovery and Synthesis of C-Nucleosides as Potential New Anti-HCV Agents.
June 2014, ACS medicinal chemistry letters,
Shuang Guo, and Mingshuo Xu, and Qi Guo, and Fuqiang Zhu, and Xiangrui Jiang, and Yuanchao Xie, and Jingshan Shen
4'-Substituted pyrimidine nucleosides lacking 5'-hydroxyl function as potential anti-HCV agents.
March 2014, Bioorganic & medicinal chemistry letters,
Shuang Guo, and Mingshuo Xu, and Qi Guo, and Fuqiang Zhu, and Xiangrui Jiang, and Yuanchao Xie, and Jingshan Shen
Synthesis of pyrrolo[2,3-d]pyrimidine nucleoside derivatives as potential anti-HCV agents.
February 2007, Bioorganic chemistry,
Shuang Guo, and Mingshuo Xu, and Qi Guo, and Fuqiang Zhu, and Xiangrui Jiang, and Yuanchao Xie, and Jingshan Shen
Synthesis of 2'-fluoro and 2',4'-dimethyl pyrimidine C-nucleoside analogues as potential anti-HCV agents.
March 2010, Nucleosides, nucleotides & nucleic acids,
Shuang Guo, and Mingshuo Xu, and Qi Guo, and Fuqiang Zhu, and Xiangrui Jiang, and Yuanchao Xie, and Jingshan Shen
Synthesis of 3'-C-hydroxymethyl-substituted pyrimidine and purine nucleosides as potential anti-hepatitis C virus (HCV) agents.
July 2008, Archives of pharmacal research,
Shuang Guo, and Mingshuo Xu, and Qi Guo, and Fuqiang Zhu, and Xiangrui Jiang, and Yuanchao Xie, and Jingshan Shen
Discovery of Novel Pyrimidine-Based Capsid Assembly Modulators as Potent Anti-HBV Agents.
May 2021, Journal of medicinal chemistry,
Shuang Guo, and Mingshuo Xu, and Qi Guo, and Fuqiang Zhu, and Xiangrui Jiang, and Yuanchao Xie, and Jingshan Shen
Revisiting Pyrazolo[3,4-d]pyrimidine Nucleosides as Anti-Trypanosoma cruzi and Antileishmanial Agents.
April 2021, Journal of medicinal chemistry,
Shuang Guo, and Mingshuo Xu, and Qi Guo, and Fuqiang Zhu, and Xiangrui Jiang, and Yuanchao Xie, and Jingshan Shen
Derivatives of imidazotriazine and pyrrolotriazine C-nucleosides as potential new anti-HCV agents.
November 2014, Bioorganic & medicinal chemistry letters,
Shuang Guo, and Mingshuo Xu, and Qi Guo, and Fuqiang Zhu, and Xiangrui Jiang, and Yuanchao Xie, and Jingshan Shen
Synthesis of purine modified 2'-C-methyl nucleosides as potential anti-HCV agents.
November 2011, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!